We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,756 hedge funds and large institutions have $252B invested in Johnson & Johnson in 2019 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 1,129 increasing their positions, 1,289 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 66

4.93% more ownership

Funds ownership: 68.05%72.98% (+4.9%)

0% less funds holding

Funds holding: 2,7662,756 (-10)

0% less capital invested

Capital invested by funds: $253B → $252B (-$1.14B)

7% less funds holding in top 10

Funds holding in top 10: 690639 (-51)

11% less call options, than puts

Call options by funds: $1.69B | Put options by funds: $1.9B

12% less repeat investments, than reductions

Existing positions increased: 1,129 | Existing positions reduced: 1,289

Holders
2,756
Holders Change
-10
Holders Change %
-0.36%
% of All Funds
59.85%
Holding in Top 10
639
Holding in Top 10 Change
-51
Holding in Top 10 Change %
-7.39%
% of All Funds
13.88%
New
91
Increased
1,129
Reduced
1,289
Closed
66
Calls
$1.69B
Puts
$1.9B
Net Calls
-$208M
Net Calls Change
+$260M
Name Holding Trade Value Shares
Change
Change in
Stake
PAIM
1051
Punch & Associates Investment Management
Minnesota
$6.31M +$55.6K +402 +0.9%
MKC
1052
M. Kraus & Co
Vermont
$6.29M +$102K +736 +2%
NONA
1053
Ninety One North America
New York
$6.29M -$910K -6,577 -13%
QC
1054
Quadrature Capital
United Kingdom
$6.29M -$9.97M -72,049 -61%
BCM
1055
Beddow Capital Management
Wyoming
$6.29M -$1.37M -9,885 -18%
WAM
1056
Wealthspire Advisors (Maryland)
Maryland
$6.28M -$1.26M -9,095 -17%
DF
1057
Donoghue Forlines
Massachusetts
$6.28M +$6.24M +45,060 New
AAIM
1058
American Assets Investment Management
California
$6.27M
IRF
1059
IBM Retirement Fund
New York
$6.23M +$37K +267 +0.6%
CBN
1060
Cadence Bank NA
Texas
$6.22M -$180K -1,303 -3%
WF
1061
WoodTrust Financial
Wisconsin
$6.2M +$210K +1,520 +4%
RIM
1062
Rampart Investment Management
Connecticut
$6.19M -$365K -2,638 -6%
MDCM
1063
Morgan Dempsey Capital Management
Wisconsin
$6.19M +$449K +3,242 +8%
BA
1064
BCM Advisors
Louisiana
$6.13M +$23.4K +169 +0.4%
WCM
1065
Weik Capital Management
Pennsylvania
$6.12M -$200K -1,447 -3%
CAM
1066
Cubic Asset Management
Massachusetts
$6.12M -$235K -1,699 -4%
Voloridge Investment Management
1067
Voloridge Investment Management
Florida
$6.11M +$6.07M +43,869 New
MI
1068
Markston International
New York
$6.11M -$198K -1,434 -3%
FWM
1069
Frontier Wealth Management
Missouri
$6.09M -$210K -1,520 -3%
AIM
1070
Axiom Investment Management
New York
$6.09M +$57.9K +418 +1%
MC
1071
Miramar Capital
Illinois
$6.08M +$56.8K +410 +0.9%
BWM
1072
Buckley Wealth Management
Nevada
$6.08M -$38.8K -280 -0.6%
WA
1073
WBH Advisory
Maryland
$6.06M -$267K -1,926 -4%
SIAP
1074
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$6.04M +$1.13M +8,136 +23%
CAM
1075
Cypress Asset Management
Texas
$6.04M -$362K -2,612 -6%

JNJ Hedge Fund Activity: Q2 2019 in Review

2,756 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2019, worth a combined $252B — down 0.45% from $253B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new JNJ positions and 66 closed out — a net gain of 25 holders — while 1,129 added to existing stakes and 1,289 trimmed.

The largest buyer was Phocas Financial Corp, adding an estimated $17.3B. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $719M.

  • 2,756 institutional investors held Johnson & Johnson (JNJ) as of Q2 2019, down from 2,766 in Q1 2019.
  • Funds reported $252B of Johnson & Johnson stock for Q2 2019, down 0.45% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q2 2019 and 66 closed out, a net change of +25 holders.
  • The largest Johnson & Johnson buyer in Q2 2019 was Phocas Financial Corp, an estimated $17.3B added.
  • The largest Johnson & Johnson seller in Q2 2019 was Barrow, Hanley, Mewhinney & Strauss, an estimated $719M sold.

Based on aggregated 13F filings for Q2 2019.